CRISPR Therapeutics AG
看多

4 hour bullish divergence

299
It was pointed out to me earlier that the last time I posted was back in May so I thought I’d pull my finger out and share this one.

The company has developed a cure for sickle cell disease, by gene editing, this disease is seriously debilitating and affects millions of people of African descent, this is a game changer for people with this disease.

The company are still loss making but this groundbreaking technology has the potential to cure other previously incurable diseases.

Cathie Wood has been accumulating shares in her Ark fund, it has huge potential, picked up a few shares earlier today

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。